Clinical Trial Update: Role of Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays in the Resistance of Non-small Cell Lung Cancer to Anti-PD1/PD-L1 Therapies

View source ↗

Summary

This clinical trial examines how cancer-associated fibroblasts, myeloid-derived suppressor cells, and immune cell interactions contribute to resistance to anti-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Lung Neoplasm, Cancer Associated Fibroblast | Status: NOT_YET_RECRUITING